LONDON — British drugmaker GlaxoSmithKline will next week begin shipping its swine flu vaccine Pandemrix across Europe, the group announced on Wednesday following approval by regulators.

“Following the (European) Commission’s approval we expect to commence shipments of Pandemrix to European governments from next week,” said Jean Stephenne, President of GlaxoSmithKline Biologicals, in a company statement.

The news came one day after the European Commission cleared Pandemrix and another vaccine, Focetria, for distribution in Europe. Focetria is produced by Swiss pharaceuticals group Novartis.

“GSK confirmed today that the European Commission has granted marketing authorisation of GSK’s pandemic (H1N1) adjuvanted vaccine Pandemrix for protection against pandemic H1N1 2009 influenza,” the group added Wednesday.

Full Story